WellCare Health Plans (WCG) Issues FY17 Earnings Guidance

WellCare Health Plans (NYSE:WCG) updated its FY17 earnings guidance on Monday. The company provided EPS guidance of $8.25-8.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.34. WellCare Health Plans also updated its FY18 guidance to $8.40-8.65 EPS.

A number of equities analysts have weighed in on the company. Zacks Investment Research lowered WellCare Health Plans from a strong-buy rating to a hold rating in a research note on Saturday, January 6th. Goldman Sachs Group assumed coverage on WellCare Health Plans in a research report on Wednesday, January 3rd. They set a buy rating and a $255.00 target price on the stock. ValuEngine cut WellCare Health Plans from a buy rating to a hold rating in a research report on Tuesday, December 19th. Cantor Fitzgerald restated a buy rating and set a $235.00 target price on shares of WellCare Health Plans in a research report on Monday, December 18th. Finally, Deutsche Bank raised their target price on WellCare Health Plans to $240.00 and gave the company a buy rating in a research report on Monday, November 20th. Ten analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of $210.07.

WellCare Health Plans (WCG) traded up $0.23 during mid-day trading on Thursday, reaching $205.89. The company had a trading volume of 326,840 shares, compared to its average volume of 293,605. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 0.51. WellCare Health Plans has a 12 month low of $136.23 and a 12 month high of $213.97. The firm has a market cap of $9,240.00, a PE ratio of 25.83, a price-to-earnings-growth ratio of 1.60 and a beta of 0.82.

WellCare Health Plans (NYSE:WCG) last issued its earnings results on Tuesday, October 31st. The company reported $4.08 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.90 by $2.18. The business had revenue of $4.40 billion for the quarter, compared to analysts’ expectations of $4.37 billion. WellCare Health Plans had a return on equity of 30.69% and a net margin of 3.90%. The business’s revenue for the quarter was up 22.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.63 EPS. equities research analysts anticipate that WellCare Health Plans will post 8.38 earnings per share for the current fiscal year.

In other news, Director Carol Burt sold 997 shares of the business’s stock in a transaction that occurred on Tuesday, November 7th. The stock was sold at an average price of $202.20, for a total transaction of $201,593.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.47% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “WellCare Health Plans (WCG) Issues FY17 Earnings Guidance” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally copied and republished in violation of United States & international copyright laws. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/01/11/wellcare-health-plans-wcg-issues-fy17-earnings-guidance.html.

About WellCare Health Plans

WellCare Health Plans, Inc is a managed care company. The Company focuses on government-sponsored managed care services, primarily through Medicaid, Medicare Advantage (MA) and Medicare Prescription Drug Plans (PDPs), to families, children, seniors and individuals with medical needs. The Company operates through three segments: Medicaid Health Plans, Medicare Health Plans and Medicare PDPs.

Earnings History and Estimates for WellCare Health Plans (NYSE:WCG)

Receive News & Ratings for WellCare Health Plans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WellCare Health Plans and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply